Infection News

A study published in Gastroenterology highlights specific markers of stool fungi combined with host immune factors to differentiate Clostridioides difficile infected patients from carrier patients.

Between April and July last year, there was a more than 80% decline in the incidence of reported norovirus outbreaks in nine U.S. states, likely the result of nonpharmaceutical interventions to combat COVID-19, researchers reported.

The agency authorized the test for non-prescription, home use in adults for self-swabbing and for children aged 2 years and older when swabbed by an adult.

Patients with COVID-19 who presented with gastrointestinal symptoms had reduced mortality, according to research published in Gastroenterology.

Outpatient diverticulitis treatment with amoxicillin-clavulanate was “just as effective” as treatment with a combination of metronidazole and a fluoroquinolone, a researcher told Healio Primary Care.

Communities with lower socioeconomic status have a higher incidence of community-associated Clostridioides difficile infection, according to study results published in Clinical Infectious Diseases.

Healio Gastroenterology presents the following reports on the most recent research on the intersection of COVID-19 and gastroenterology.

There was no reduced risk for COVID-19 outcomes among hospitalized patients treated with famotidine, according to study results.

Children with inflammatory bowel disease who contract COVID-19 generally have mild disease, according to study results.

Fecal microbiota transplantation appeared safe with low risk for transmission of infection in patients with recurrent Clostridioides difficile infection, according to study results.